DK128285A - Cyclosporinderivater - Google Patents

Cyclosporinderivater Download PDF

Info

Publication number
DK128285A
DK128285A DK128285A DK128285A DK128285A DK 128285 A DK128285 A DK 128285A DK 128285 A DK128285 A DK 128285A DK 128285 A DK128285 A DK 128285A DK 128285 A DK128285 A DK 128285A
Authority
DK
Denmark
Prior art keywords
cyclosporin derivatives
cyclosporin
derivatives
Prior art date
Application number
DK128285A
Other languages
Danish (da)
English (en)
Other versions
DK128285D0 (da
Inventor
Roland Wenger
Rene P Traber
Hans Kobel
Hans Hofmann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848407618A external-priority patent/GB8407618D0/en
Priority claimed from GB848411922A external-priority patent/GB8411922D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK128285D0 publication Critical patent/DK128285D0/da
Publication of DK128285A publication Critical patent/DK128285A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK128285A 1984-03-23 1985-03-21 Cyclosporinderivater DK128285A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848407618A GB8407618D0 (en) 1984-03-23 1984-03-23 Organic compounds
GB848411922A GB8411922D0 (en) 1984-05-10 1984-05-10 Organic compounds

Publications (2)

Publication Number Publication Date
DK128285D0 DK128285D0 (da) 1985-03-21
DK128285A true DK128285A (da) 1985-09-24

Family

ID=26287502

Family Applications (1)

Application Number Title Priority Date Filing Date
DK128285A DK128285A (da) 1984-03-23 1985-03-21 Cyclosporinderivater

Country Status (24)

Country Link
US (1) US4639434A (en:Method)
JP (1) JPH08838B2 (en:Method)
AT (1) AT388737B (en:Method)
BE (1) BE901980A (en:Method)
CA (1) CA1247546A (en:Method)
CH (1) CH667274A5 (en:Method)
CS (1) CS249542B2 (en:Method)
DE (1) DE3509809A1 (en:Method)
DK (1) DK128285A (en:Method)
ES (1) ES8702926A1 (en:Method)
FI (1) FI851120L (en:Method)
FR (1) FR2561651B1 (en:Method)
GB (1) GB2155936B (en:Method)
GR (1) GR850716B (en:Method)
HU (1) HU200786B (en:Method)
IL (1) IL74681A (en:Method)
IT (1) IT1199962B (en:Method)
LU (1) LU85819A1 (en:Method)
NL (1) NL8500828A (en:Method)
NO (1) NO851160L (en:Method)
NZ (1) NZ211526A (en:Method)
PH (2) PH21868A (en:Method)
PT (1) PT80149B (en:Method)
SE (1) SE461334B (en:Method)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314862A1 (en) 1984-10-04 1989-05-10 Sandoz Ag Immunogenic conjugates comprising cyclosporins
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
ES2059558T3 (es) * 1987-06-17 1994-11-16 Sandoz Ag Ciclosporins y su uso como productos farmaceuticos.
EP0373260B1 (en) * 1987-06-22 1994-03-09 Merck & Co. Inc. Cyclosporin derivatives with modified "8-amino acid"
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
WO1989001772A1 (en) * 1987-09-03 1989-03-09 University Of Georgia Research Foundation, Inc. Ocular cyclosporin composition
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
CH679119A5 (en:Method) * 1988-05-13 1991-12-31 Sandoz Ag
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
ES2095926T5 (es) * 1990-11-02 2001-02-16 Novartis Ag Cyclosporins.
ES2181734T3 (es) 1990-11-20 2003-03-01 Dade Behring Marburg Gmbh Ensayo inmunologico de ciclosporina.
US5747330A (en) * 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
RU2170741C2 (ru) * 1996-08-16 2001-07-20 Новартис Аг Способ получения циклоспорина
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
KR100585348B1 (ko) 1997-10-08 2006-06-01 이소테크니카 인코포레이티드 중수소화된 시클로스포린 유사체 및 면역조절제로서 그의용도
US5990274A (en) 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
US7449544B2 (en) * 1999-11-30 2008-11-11 Cyclacel Limited p21 peptides
ES2330625T3 (es) * 2001-10-19 2009-12-14 Isotechnika Inc. Preconcentrados de microemulsion de analogos de ciclosporina novedosos.
NZ531944A (en) * 2001-10-19 2006-03-31 Isotechnika Inc Synthesis of cyclosporin analogs
AU2004222306A1 (en) * 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
EP1804823A4 (en) * 2004-09-29 2010-06-09 Amr Technology Inc NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS
US7378391B2 (en) * 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
EP1812037A4 (en) * 2004-10-06 2009-11-11 Amr Technology Inc ALKYNES OF CYCLOSPORINE AND THEIR USEFUL AS PHARMACEUTICAL AGENTS
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7576057B2 (en) 2006-11-20 2009-08-18 Scynexis, Inc. Cyclic peptides
PT2651965T (pt) 2010-12-15 2019-01-28 Contravir Pharmaceuticals Inc Moléculas analógas de ciclosporinas modificadas ao nivel dos aminoácidos 1 e 3
ES2973062T3 (es) 2011-03-11 2024-06-18 Beth Israel Deaconess Medical Ct Inc Anticuerpos anti-CD40 y usos de los mismos
CN104877013B (zh) * 2015-06-03 2018-04-20 兰州大学 环孢菌素t及其制备方法和应用
EP3307322B1 (en) 2015-09-04 2021-02-17 Primatope Therapeutics Inc. Humanized anti-cd40 antibodies and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140753A (en) * 1981-01-09 1982-08-31 Sandoz Ag Novel cyclosporine
DE3260468D1 (en) * 1981-01-09 1984-09-06 Sandoz Ag Novel cyclosporins

Also Published As

Publication number Publication date
PT80149A (en) 1985-04-01
IT8547852A1 (it) 1986-09-22
CH667274A5 (de) 1988-09-30
BE901980A (fr) 1985-09-23
LU85819A1 (fr) 1985-12-12
GB2155936A (en) 1985-10-02
IL74681A (en) 1989-09-10
PT80149B (en) 1987-03-23
IT1199962B (it) 1989-01-05
FR2561651B1 (fr) 1990-03-09
SE8501392L (sv) 1985-09-24
SE8501392D0 (sv) 1985-03-21
JPS60215700A (ja) 1985-10-29
CS249542B2 (en) 1987-03-12
ES541465A0 (es) 1987-01-16
FI851120A7 (fi) 1985-09-24
NL8500828A (nl) 1985-10-16
FI851120A0 (fi) 1985-03-20
FR2561651A1 (fr) 1985-09-27
IT8547852A0 (it) 1985-03-22
PH23357A (en) 1989-07-14
PH21868A (en) 1988-03-25
DK128285D0 (da) 1985-03-21
GB2155936B (en) 1987-09-16
HUT38370A (en) 1986-05-28
AT388737B (de) 1989-08-25
NO851160L (no) 1985-09-24
US4639434A (en) 1987-01-27
IL74681A0 (en) 1985-06-30
NZ211526A (en) 1988-08-30
GR850716B (en:Method) 1985-07-19
FI851120L (fi) 1985-09-24
GB8507270D0 (en) 1985-04-24
DE3509809A1 (de) 1986-01-09
HU200786B (en) 1990-08-28
JPH08838B2 (ja) 1996-01-10
SE461334B (sv) 1990-02-05
ATA86385A (de) 1989-01-15
CA1247546A (en) 1988-12-28
ES8702926A1 (es) 1987-01-16

Similar Documents

Publication Publication Date Title
DK128285A (da) Cyclosporinderivater
DK268285D0 (da) Dialkoxypyridinderivater
DK35785D0 (da) Tetrahydrocarbazolonderivater
DK243985A (da) Aminoalkylphenoxyderivater
DE3463503D1 (de) Sulfonamido-benzamide derivatives
ATA232984A (de) Hoergeraet
DK400485A (da) Cyclosporinterapi
DE3566887D1 (de) Flavanon derivatives
DK524585D0 (da) Cholecalciferolderivater
DK155985D0 (da) Cephem-derivater
DK443685D0 (da) Pirimidinderivater
ATA98284A (de) Schalplatte
DK320585D0 (da) Fluorallylaminderivater
ES539508A0 (es) Derivados de androsteno nuevos
DK514585A (da) Aminoethylanilinderivater
DE3565100D1 (de) Cycloalkane-indene-carboximidamide derivatives
DK267190A (da) 13-substitueret-5-ketomilbemycinderivater
DK14485A (da) Naphthalenderivater
DK54085A (da) Phenylpropargylaminderivater
DK161783C (da) Roerformet lyddaemper
DE3564269D1 (de) Eburnane derivatives
NO1997011I1 (no) Tacrolimus
DK101986D0 (da) Kopelevator
ES529437A0 (es) Derivados de 3-pirrolidinopropiofenona
ES277139Y (es) Complejo mueble-bar-nevera

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment